CardCash.com to Offer Cost-Effective Solutions for High-Demand GLP-1 Medications as Prescription Drug Market Grows SCHAUMBURG, IL / ACCESS ...

Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

Kwame Raoul is among several state AGs raising the alarm following complaints about online teleheath company Hims & Hers ...

Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...

Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.

Several local companies are developing technologies that they hope could replace a painful poke with something that feels more like having Velcro against your skin for a few minutes.

There are many opportunities available in the international markets that never make the news in the US. The VEA and VWO ETFs ...

These three stocks just announced significant quarterly dividend increases that they are set to pay out soon. While they all raised dividends by a minimum of 15%, two announced raises north of 35%.

When celebrities reveal their experiences with newer weight-loss drugs, there are upsides and downsides for patients and ...

Small studies link Ozempic and similar drugs to rare but serious eye conditions. However, experts say there's no need to ...

Six percent of Americans have used Ozempic, Wegovy and similar drugs. They’re unwitting experimental subjects.

The manufacturer of the weight loss jab Wegovy has been reprimanded for allegedly failing to disclose or accurately report payments to healthcare and patient organisations.